Hodgkin's disease incidence and survival in European children and adolescents (1978-1997): Report from the Automated Cancer Information System Project

被引:50
作者
Clavel, J. [1 ]
Steliarova-Foucher, E.
Berger, C.
Danon, S.
Valerianova, Z.
机构
[1] INSERM, French Natl Registry Childhood Hematopoiet Malign, U754, IFR69, Villejuif, France
[2] Int Agcy Res Canc, Descript Epidemiol Grp, F-69372 Lyon, France
[3] Childhood Canc Registry Rhone Alpes, St Etienne, France
[4] Natl Oncol Hosp, Bulgarian Natl Canc Registry, Sofia, Bulgaria
关键词
Hodgkin's disease; childhood cancer; adolescents; Europe; registry; incidence; survival;
D O I
10.1016/j.ejca.2006.05.012
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
This paper reports the geographical patterns and time trends of incidence and survival of Hodgkin's disease (HD) in children and adolescents in Europe over the period 1978-1997. Data on 4230 HD cases were gathered from 62 paediatric or general cancer registries in 19 European countries by the Automated Cancer Information System (ACCIS). European annual incidence rates in 1988-1997 were estimated at 5.8 per million in children (world age-standardised) and at 29.7 per million in adolescents, with higher rates in the East and South. Incidence rates increased steeply with age, while the male predominance, marked for the youngest children, vanished in the highest age groups. Over the period 1978-1997 incidence rates increased in age groups 10-14 years (+1% per year) and 15-19 years (+3.5% per year), mainly due to the nodular sclerosis subtype. Age and sex distribution of cases remained unchanged with time. The overall 5-year survival rate was higher in children (93%, 95% confidence interval (CI) 92-94) than in adolescents (89% (95% CI 8791)) for the period 1988-1997. Five-year survival increased significantly in all regions from 87% to 93% in children and from 80% to 88% in adolescents between 1978-1982 and 1993-1997. In future, detailed documentation of cases in the cancer registries with respect to standardised diagnostic subtypes, stage of extension, and treatments, will help to refine interpretation of international and temporal variations in incidence and survival. (c) 2006 Elsevier Ltd. All rights reserved.
引用
收藏
页码:2037 / 2049
页数:13
相关论文
共 35 条
[1]   Epstein-Barr virus and Hodgkin's disease: Further evidence for the three disease hypothesis [J].
Armstrong, AA ;
Alexander, FE ;
Cartwright, R ;
Angus, B ;
Krajewski, AS ;
Wright, DH ;
Lee, F ;
Kane, E ;
Jarrett, RF .
LEUKEMIA, 1998, 12 (08) :1272-1276
[2]   Classification and incidence of cancers in adolescents and young adults in England 1979-1997 [J].
Birch, JM ;
Alston, RD ;
Kelsey, AM ;
Quinn, MJ ;
Babb, P ;
McNally, RJQ .
BRITISH JOURNAL OF CANCER, 2002, 87 (11) :1267-1274
[3]   Cancer in older adolescents and young adults: Epidemiology, diagnosis, treatment, survival, and importance of clinical trials [J].
Bleyer, WA .
MEDICAL AND PEDIATRIC ONCOLOGY, 2002, 38 (01) :1-10
[4]   Should adolescents with acute lymphoblastic leukemia be treated as old children or young adults?: Comparison of the French FRALLE-93 and LALA-94 trials [J].
Boissel, N ;
Auclerc, MF ;
Lhéritier, V ;
Perel, Y ;
Thomas, X ;
Leblanc, T ;
Rousselot, P ;
Cayuela, JM ;
Gabert, J ;
Fegueux, N ;
Piguet, C ;
Huguet-Rigal, F ;
Berthou, C ;
Boiron, JM ;
Poutos, C ;
Michel, G ;
Fière, D ;
Leverger, G ;
Dombret, H ;
Baruchel, A .
JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (05) :774-780
[5]   Up-to-date survival curves of children with cancer by period analysis [J].
Brenner, H .
BRITISH JOURNAL OF CANCER, 2003, 88 (11) :1693-1697
[6]   IL-6 levels and genotype are associated with risk of young adult Hodgkin lymphoma [J].
Cozen, W ;
Gill, PS ;
Ingles, SA ;
Masood, R ;
Martínez-Maza, O ;
Cockburn, MG ;
Gauderman, WJ ;
Pike, MC ;
Bernstein, L ;
Nathwani, BN ;
Salam, MT ;
Danley, KL ;
Wang, W ;
Gage, J ;
Gundell-Miller, S ;
Mack, TM .
BLOOD, 2004, 103 (08) :3216-3221
[7]   Genetic susceptibility to Hodgkin's lymphoma associated with the human leukocyte antigen region [J].
Diepstra, A ;
Niens, M ;
te Meerman, GJ ;
Poppema, S ;
van den Berg, A .
EUROPEAN JOURNAL OF HAEMATOLOGY, 2005, 75 :34-41
[8]   Hodgkin lymphoma and Epstein-Barr virus (EBV): No evidence to support hit-and-run mechanism in cases classified as non-EBV-associated [J].
Gallagher, A ;
Perry, J ;
Freeland, J ;
Alexander, FE ;
Carman, WF ;
Shield, L ;
Cartwright, R ;
Jarrett, RF .
INTERNATIONAL JOURNAL OF CANCER, 2003, 104 (05) :624-630
[9]   Viruses and Hodgkin disease: No evidence of novel herpesviruses in non-EBV-associated lesions [J].
Gallagher, A ;
Perry, J ;
Shield, L ;
Freeland, J ;
MacKenzie, J ;
Jarrett, RF .
INTERNATIONAL JOURNAL OF CANCER, 2002, 101 (03) :259-264
[10]   Childhood cancer survival trends in Europe: A EUROCARE working group study [J].
Gatta, G ;
Capocaccia, R ;
Stiller, C ;
Kaatsch, P ;
Berrino, F ;
Terenziani, M .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) :3742-3751